Concepedia

Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

Jonathan S. Berek, Maurie Markman, Bette Stonebraker, Samuel S. Lentz, Mark Adelson, Koen DeGeest, David H. Moore

Gynecologic Oncology · 1999 · 56 citations · 15 references

DOI

Concepts

References

15

Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

David S. Alberts, P. Y. Liu, Edward V. Hannigan et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text

, , +5

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Dedrick Rl, Myers Ce, Bungay Pm et al. · PubMed · 1978 · 743 citations

, , +17

Intraperitoneal Cisplatin with Systemic Thiosulfate Protection

Stephen B. Howell · Annals of Internal Medicine · 1982 · 486 citations

, , +17

Practical Gynecologic Oncology

Arnold M. Markoe · American Journal of Clinical Oncology · 1990 · 197 citations

Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Jonathan S. Berek, Neville F. Hacker, Alan Lichtenstein et al. · PubMed · 1985 · 182 citations

, , +17